A Multidisciplinary Overview of Peripheral Artery Disease: Part 2
Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals
00:00
Introduction
All patients of peripheral artery disease should be on an antiplatelet therapy consisting of either aspirin or clopidogrel in most cases. There are injectable medicines specifically monoclonal antibody PCSK9 inhibitors and the names for those are allerockumab and evolockumab, they have a very prominent reduction in LDL cholesterol. And what we try and target is LDL cholesterol at least less than 70 but actually more recent guidelines particularly European guidelines pushing that even lower to LDL cholesterol less than 55.
Play episode from 00:00
Transcript
